Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Berlin

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Cancer Medicine|September 21, 2021
Racial disparity in taxane-induced neutropenia among cancer patientsNeil S Zheng, Fei Wang, Rajiv Agarwal, et al.
Oncology|August 25, 2010
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort studyMark F Kozloff, Jordan Berlin, Patrick J Flynn, et al.
Virchows Archiv : an International Journal of Pathology|February 19, 2017
In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneousMongkon Charoenpitakchai, Eric Liu, Zhiguo Zhao, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Cancers|July 27, 2022
Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United StatesFei Wang, Xiang Shu, Tuya Pal, et al.
International Journal of Yoga Therapy|November 1, 2016
Intervention Protocol for Investigating Yoga Implemented During ChemotherapyStephanie J Sohl, Gurjeet S Birdee, Sheila H Ridner, et al.
Clinical Colorectal Cancer|May 29, 2007
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancerJordan Berlin, James Posey, Simon Tchekmedyian, et al.
Cancers|January 21, 2022
Trends in the Incidence and Treatment of Early-Onset Pancreatic CancerMichael LaPelusa, Chan Shen, Nina D Arhin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancerHerbert I Hurwitz, Louis Fehrenbacher, John D Hainsworth, et al.
Journal of Surgical Oncology|September 24, 2017
Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinomaKamran Idrees, Chandrasekhar Padmanabhan, Eric Liu, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Cancer Medicine|September 21, 2021
Racial disparity in taxane-induced neutropenia among cancer patientsNeil S Zheng, Fei Wang, Rajiv Agarwal, et al.
Oncology|August 25, 2010
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort studyMark F Kozloff, Jordan Berlin, Patrick J Flynn, et al.
Virchows Archiv : an International Journal of Pathology|February 19, 2017
In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneousMongkon Charoenpitakchai, Eric Liu, Zhiguo Zhao, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Cancers|July 27, 2022
Racial/Ethnic Disparities in Mortality Related to Access to Care for Major Cancers in the United StatesFei Wang, Xiang Shu, Tuya Pal, et al.
International Journal of Yoga Therapy|November 1, 2016
Intervention Protocol for Investigating Yoga Implemented During ChemotherapyStephanie J Sohl, Gurjeet S Birdee, Sheila H Ridner, et al.
Clinical Colorectal Cancer|May 29, 2007
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancerJordan Berlin, James Posey, Simon Tchekmedyian, et al.
Cancers|January 21, 2022
Trends in the Incidence and Treatment of Early-Onset Pancreatic CancerMichael LaPelusa, Chan Shen, Nina D Arhin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancerHerbert I Hurwitz, Louis Fehrenbacher, John D Hainsworth, et al.
Journal of Surgical Oncology|September 24, 2017
Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinomaKamran Idrees, Chandrasekhar Padmanabhan, Eric Liu, et al.
Pageof 15